Asia-Pacific Biosensors Market is expected to reach USD 7,184.0 million by 2024 from USD 3,424.5 million in 2016, at a CAGR of 9.8% in the forecast period 2017 to 2024.

The major factors driving the growth of this Asia-Pacific biosensors market are increasing use of biosensors to monitor glucose levels in individuals with diabetes and rising demand for disposable, cost-efficient & user-friendly devices of the market are furthermore boosting the growth of the global biosensor market. The biosensors market in the Asia-Pacific region is leading in India.


The key market players for Asia-Pacific Biosensors Market are listed below;

Abbott
Johnsons & Johnson Services, Inc.
Medtronic

The market is further segmented into;
product type
Application
technology
industry
Geography

The Asia-Pacific biosensors market is segmented on the basis of product type, application, technology and end user.
On the basis of technology, the Asia-Pacific biosensor market is segmented into electrochemical biosensors, optical biosensors, piezoelectric biosensors, nanomechanical biosensors, thermal biosensors and others. The Asia-Pacific biosensor market is dominated by electrochemical biosensors with 41.8% market share in 2017, growing with a CAGR of 9.4% in the forecast period. Electrochemical biosensors are sub segmented into amperometric sensors, potentiometric sensors and conductometric sensors. Amperometric sensors are further sub segmented into blood glucose sensors. Potentiometric sensors are further sub segmented into immunosensors, penicillin biosensor and urea biosensor.
Optical biosensors are further sub segmented into surface plasmon resonance (SPR), calorimetric biosensors and fluorescence biosensors.
Piezoelectric biosensors are further sub segmented into acoustic biosensors and microcantilever biosensors.
On the basis of product, the Asia-Pacific biosensor market is segmented into wearable biosensors and non-wearable biosensors. Wearable biosensors are expected to dominate the Asia-Pacific biosensor market with 80.0% market share. Wearable biosensors are further sub segmented into wrist wear, eyewear, footwear, neckwear, body wear and others.
On the basis of application, the Asia-Pacific biosensor market is classified into point of care (POC), home diagnostics and biodefence, environmental monitoring, food & beverage industry and research labs. In 2017, point of care (POC) is expected to dominate the market with 53.4% market share. Point of care (POC) are further sub segmented into glucose monitoring, cardiac markers, infectious diseases, coagulation monitoring, pregnancy & fertility testing, blood gas & electrolytes, tumor or cancer markers, urinalysis testing, cholesterol tests and others.
Based on geography, the Asia-Pacific Biosensors market is segmented into geographical regions, such as,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines
Rest of Asia-Pacific

Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Biosensors market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.